Preclinical pharmacokinetics of paclitaxel and docetaxel

A Sparreboom, O Van Tellingen, WJ Nooijen… - Anti-cancer …, 1998 - journals.lww.com
The taxanes paclitaxel and docetaxel represent a novel class of antlneoplastic agents. A
major problem of both drugs is their low aqueous solubility and the design of suitable …

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

…, DKF Meijer, P Borst, WJ Nooijen… - Proceedings of the …, 1997 - National Acad Sciences
In mice, the mdr1a and mdr1b genes encode drug-transporting proteins that can cause
multidrug resistance in tumor cells by lowering intracellular drug levels. These P-glycoproteins …

Insulin resistance and breast‐cancer risk

…, M de Jong‐Bakker, WJ Nooijen - … Journal of Cancer, 1992 - Wiley Online Library
Life‐style has a major influence on the incidence of breast cancer. To evaluate the effects of
life‐style related metabolic‐endocrine factors on breast cancer risk we conducted a case‐…

Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL

A Sparreboom, O van Tellingen, WJ Nooijen… - Cancer research, 1996 - AACR
Studies in humans and mice have demonstrated a nonlinear pharmacokinetic behavior of
paclitaxel. Because of its poor water solubility, the drug is formulated in a mixture of …

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

…, VR Panday, JHM Schellens, WJ Nooijen… - British journal of …, 1999 - nature.com
The non-linear plasma pharmacokinetics of paclitaxel in patients has been well established,
however, the exact underlying mechanism remains to be elucidated. We have previously …

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833

…, AH Schinkel, P Borst, WJ Nooijen… - British journal of …, 1997 - nature.com
Inhibition of intestinal P-glycoprotein might enhance the absorption of orally administered P-glycoprotein
substrate drugs. We show here a 10-fold increased oral bioavailability of …

Tissue distribution, metabolism and excretion of paclitaxel in mice

A Sparreboom, O van Tellingen, WJ Nooijen… - Anti-cancer …, 1996 - journals.lww.com
So far, all animal pharmacokinetic studies of paclitaxel, which used analytical procedures
based on HPLC, have not been sensitive enough to quantify drug levels below 500 ng/ml. …

Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice

…, AH Schinkel, JH Beijnen, WJ Nooijen… - JNCI: Journal of the …, 1996 - academic.oup.com
Background: P-glycoprotein (Pgp) is a membrane protein that acts as an extrusion pump for
many cytotoxic drugs. Pgp is expressed in normal tissues, and its (over)expression in tumor …

Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice

…, J Verweij, EJ Scherrenburg, WJ Nooijen… - Clinical cancer …, 1999 - AACR
We have developed and validated an analytical methodology for the quantification of
docetaxel and its four major human oxidation metabolites in mouse plasma. We have used this …

[PDF][PDF] Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous GM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients

…, WR Gerritsen, SM Clift, WJ Nooijen… - Journal of clinical …, 2005 - researchgate.net
Purpose To determine the feasibility, toxicity, and immunologic effects of vaccination with
autologous tumor cells retrovirally transduced with the GM-CSF gene, we performed a …